))
COVID Updates: A Podcast with Peter Chin-Hong and Lona Mody
Manage episode 447781771 series 3563159
Conteúdo fornecido por GeriPal, Alex Smith, and Eric Widera. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por GeriPal, Alex Smith, and Eric Widera ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
In March 2020, we launched our first podcast on COVID-19. Over the past four years, we’ve seen many changes—some positive, some negative. While many of us are eager to move past COVID (myself included), it’s clear that COVID is here to stay.
This week, we sit down with infectious disease experts Peter Chin-Hong and Lona Mody to discuss living with COVID-19. Our conversation covers:
The current state of COVID
Evidence for COVID boosters, who should get them, and preferences between Novavax and mRNA vaccines
COVID treatments like Molnupiravir and Paxlovid
Differences in COVID impact on nursing home residents and those with serious illnesses
We wrap up with a “magic wand” question. My wish was for better randomized evidence for vaccines and treatments, though I worry this might not be feasible. In the meantime, there’s significant room to improve vaccine uptake among high-risk groups, particularly nursing home residents. Currently, only 1 in 5 nursing home residents in the US have received the COVID booster, compared to over 50% in the UK.
By: Eric Widera
338 episódios
Compartilhar
